Drug General Information (ID: D0595)
  Drug Name
Erlotinib
  Drug Type Small molecule
  Drug Synonymous
Erlotinin; Tarceva; Erlotinib Base; OSI 744; R 1415; CP 358,774; CP-358774; Erlotinib(Tarceva); Tarceva (TN); CP-358,774; Erlotinib, OS-774; N-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-Quinazolinamine; [6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE; [6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine; 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; 4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline
    Click to Show/Hide
  Disease Class 2C25: Lung cancer; 2B90: Colon cancer; 2C10: Pancreatic cancer
  Therapeutic Class Antineoplastics
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C22H23N3O4
  InChI 1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
  InChIKey AAKJLRGGTJKAMG-UHFFFAOYSA-N
  Canonical SMILES COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
  External Link
Pubchem ID 176870
CAS Number 183321-74-6
CHEBI ID 114785
TTD ID D07POC
VARIDT ID DR00558

Drug-Drug Interaction Network
  Sunburst Graph
AM001  Affected gastrointestinal absorption
AM002  Affected cellular transport
AM003  Affected organization distribution
AM004  Affected intra/extra-hepatic metabolism
AM006  Pharmacodynamic additive effects
BM005  Altered gastric pH
BM010  Transporter inhibition
BM013  Competitive binding of plasma proteins
BM017  CYP450 enzyme inhibition
BM022  CYP450 enzyme induction
BM024  Competitive inhibition of metabolic enzyme
BM043  Additive immunosuppressive effects
BM055  Increased risk of hepatotoxicity
BM075  Increased risk of photosensitivity reactions
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Erlotinib
      Affected gastrointestinal absorption
   Altered gastric pH Drug Num:  20
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0458
 
Dexlansoprazole
 
C16H14F3N3O2S
 
9578005 
Major    Inter Info   
[3], [4], [5], [6]
D0603
 
Esomeprazole
 
C17H19N3O3S
 
9568614 
Major    Inter Info   
[3], [4], [5], [6]
D1373
 
Rabeprazole
 
C18H21N3O3S
 
5029 
Major    Inter Info   
[3], [4], [5], [6]
D0892
 
Lansoprazole
 
C16H14F3N3O2S
 
3883 
Major    Inter Info   
[3], [4], [5], [6]
D1179
 
Omeprazole
 
C17H19N3O3S
 
4594 
Major    Inter Info   
[3], [4], [5], [6]
D1222
 
Pantoprazole
 
C16H15F2N3O4S
 
4679 
Major    Inter Info   
[3], [4], [5], [6]
D0337
 
Cimetidine
 
C10H16N6S
 
2756 
Moderate    Inter Info   
[3], [4], [5], [6]
D0049
 
Aluminum hydroxide
 
AlH3O3
 
10176082 
Moderate    Inter Info   
[3], [4], [5], [6]
D0236
 
Calcium carbonate
 
CCaO3
 
10112 
Moderate    Inter Info   
[3], [4], [5], [6]
D0636
 
Famotidine
 
C8H15N7O2S3
 
5702160 
Moderate    Inter Info   
[3], [4], [5], [6]
D0967
 
Magaldrate
 
AlHMgO5S+2
 
3086011 
Moderate    Inter Info   
[3], [4], [5], [6]
D0968
 
Magnesium carbonate
 
CMgO3
 
11029 
Moderate    Inter Info   
[3], [4], [5], [6]
D0973
 
Magnesium hydroxide
 
H2MgO2
 
14791 
Moderate    Inter Info   
[3], [4], [5], [6]
D0974
 
Magnesium oxide
 
MgO
 
14792 
Moderate    Inter Info   
[3], [4], [5], [6]
D1151
 
Nizatidine
 
C12H21N5O2S2
 
3033637 
Moderate    Inter Info   
[3], [4], [5], [6]
D1381
 
Ranitidine
 
C13H22N4O3S
 
3001055 
Moderate    Inter Info   
[3], [4], [5], [6]
D1382
 
Ranitidine (bismuth citrate)
 
C13H22N4O3S
 
3001055 
Moderate    Inter Info   
[3], [4], [5]
D1480
 
Sodium bicarbonate
 
CHNaO3
 
516892 
Moderate    Inter Info   
[3], [4], [5], [6]
D1483
 
Sodium citrate
 
C6H5Na3O7
 
6224 
Moderate    Inter Info   
[3], [4], [5], [6]
D1489
 
Sodium zirconium cyclosilicate
 
H6Na2O9Si3Zr+2
 
91799284 
Moderate    Inter Info   
[4], [82]
      Affected cellular transport
   Transporter inhibition Drug Num:  14
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0044
 
Alpelisib
 
C19H22F3N5O2S
 
56649450 
Moderate    Inter Info   
[4], [29], [30]
D0204
 
Brigatinib
 
C29H39ClN7O2P
 
68165256 
Moderate    Inter Info   
[4], [34], [35]
D0251
 
Capmatinib
 
C23H17FN6O
 
25145656 
Moderate    Inter Info   
[37]
D0408
 
Daclatasvir
 
C40H50N8O6
 
25154714 
Moderate    Inter Info   
[4], [39]
D0569
 
Encorafenib
 
C22H27ClFN7O4S
 
50922675 
Moderate    Inter Info   
[4], [44]
D0590
 
Erdafitinib
 
C25H30N6O2
 
67462786 
Moderate    Inter Info   
[45]
D0699
 
Fostamatinib
 
C23H26FN6O9P
 
11671467 
Moderate    Inter Info   
[48]
D0725
 
Glasdegib
 
C21H22N6O
 
25166913 
Moderate    Inter Info   
[4], [49]
D0785
 
Ibrutinib
 
C25H24N6O2
 
24821094 
Moderate    Inter Info   
[4], [50]
D0897
 
Lasmiditan
 
C19H18F3N3O2
 
11610526 
Moderate    Inter Info   
[56]
D0898
 
Ledipasvir
 
C49H54F2N8O6
 
67505836 
Moderate    Inter Info   
[57]
D1062
 
Midostaurin
 
C35H30N4O4
 
9829523 
Moderate    Inter Info   
[4]
D1423
 
Rolapitant
 
C25H26F6N2O2
 
10311306 
Moderate    Inter Info   
[80]
D1608
 
Tolvaptan
 
C26H25ClN2O3
 
216237 
Moderate    Inter Info   
[3], [4], [84], [85]
      Affected organization distribution
   Competitive binding of plasma proteins Drug Num:  3
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0481
 
Dicoumarol
 
C19H12O6
 
54676038 
Moderate    Inter Info   
[25], [6], [26]
D0087
 
Anisindione
 
C16H12O3
 
2197 
Moderate    Inter Info   
[6], [26]
D1711
 
Warfarin
 
C19H16O4
 
54678486 
Moderate    Inter Info   
[6], [26]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme inhibition Drug Num:  44
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0002
 
Abametapir (topical)
 
C12H12N2
 
15664 
Moderate    Inter Info   
[28]
D0066
 
Amiodarone
 
C25H29I2NO3
 
2157 
Moderate    Inter Info   
[6]
D0080
 
Amprenavir
 
C25H35N3O6S
 
65016 
Moderate    Inter Info   
[13], [6]
D0116
 
Atazanavir
 
C38H52N6O7
 
148192 
Moderate    Inter Info   
[13], [6]
D0192
 
Boceprevir
 
C27H45N5O5
 
10324367 
Moderate    Inter Info   
[13], [6]
D0302
 
Ceritinib
 
C28H36ClN5O3S
 
57379345 
Moderate    Inter Info   
[13], [6]
D0341
 
Ciprofloxacin
 
C17H18FN3O3
 
2764 
Moderate    Inter Info   
[6]
D0349
 
Clarithromycin
 
C38H69NO13
 
84029 
Moderate    Inter Info   
[13], [6]
D0375
 
Cobicistat
 
C40H53N7O5S2
 
25151504 
Moderate    Inter Info   
[13], [6]
D0386
 
Conivaptan
 
C32H26N4O2
 
151171 
Moderate    Inter Info   
[13], [6]
D0426
 
Darunavir
 
C27H37N3O7S
 
213039 
Moderate    Inter Info   
[40]
D0428
 
Dasatinib
 
C22H26ClN7O2S
 
3062316 
Moderate    Inter Info   
[41]
D0439
 
Delavirdine
 
C22H28N6O3S
 
5625 
Moderate    Inter Info   
[13], [6]
D0543
 
Duvelisib
 
C22H17ClN6O
 
50905713 
Moderate    Inter Info   
[42]
D0692
 
Fosamprenavir
 
C25H36N3O9PS
 
131536 
Moderate    Inter Info   
[13], [6]
D0852
 
Isavuconazonium
 
C35H35F2N8O5S+
 
6918606 
Moderate    Inter Info   
[4], [52]
D0858
 
Isoniazid
 
C6H7N3O
 
3767 
Moderate    Inter Info   
[6]
D0867
 
Itraconazole
 
C35H38Cl2N8O4
 
55283 
Moderate    Inter Info   
[13], [6]
D0869
 
Ivacaftor
 
C24H28N2O3
 
16220172 
Moderate    Inter Info   
[53]
D0880
 
Ketoconazole
 
C26H28Cl2N4O4
 
456201 
Moderate    Inter Info   
[13], [6]
D0894
 
Lapatinib
 
C29H26ClFN4O4S
 
208908 
Moderate    Inter Info   
[54]
D0896
 
Larotrectinib
 
C21H22F2N6O2
 
46188928 
Moderate    Inter Info   
[3], [4], [55]
D0899
 
Lefamulin
 
C28H45NO5S
 
25185057 
Moderate    Inter Info   
[58], [59], [60]
D0906
 
Letermovir
 
C29H28F4N4O4
 
45138674 
Moderate    Inter Info   
[62]
D0946
 
Lonafarnib
 
C27H31Br2ClN4O2
 
148195 
Moderate    Inter Info   
[13], [6]
D1057
 
Miconazole
 
C18H14Cl4N2O
 
4189 
Moderate    Inter Info   
[13], [6]
D1117
 
Nefazodone
 
C25H32ClN5O2
 
4449 
Moderate    Inter Info   
[13], [6]
D1136
 
Nilotinib
 
C28H22F3N7O
 
644241 
Moderate    Inter Info   
[68]
D1315
 
Posaconazole
 
C37H42F2N8O4
 
468595 
Moderate    Inter Info   
[13], [6]
D1408
 
Riociguat
 
C20H19FN8O2
 
11304743 
Moderate    Inter Info   
[7], [3], [4], [79]
D1444
 
Saquinavir
 
C38H50N6O5
 
441243 
Moderate    Inter Info   
[13], [6]
D1505
 
Stiripentol
 
C14H18O3
 
5311454 
Moderate    Inter Info   
[13], [6]
D1541
 
Telaprevir
 
C36H53N7O6
 
3010818 
Moderate    Inter Info   
[13], [6]
D1544
 
Telithromycin
 
C43H65N5O10
 
3002190 
Moderate    Inter Info   
[13], [6]
D1653
 
Troleandomycin
 
C41H67NO15
 
202225 
Moderate    Inter Info   
[13], [6]
D1660
 
Tucatinib
 
C26H24N8O2
 
51039094 
Moderate    Inter Info   
[13], [6]
D1690
 
Verapamil
 
C27H38N2O4
 
2520 
Moderate    Inter Info   
[6]
D1706
 
Voriconazole
 
C16H14F3N5O
 
71616 
Moderate    Inter Info   
[13], [6]
D0597
 
Erythromycin
 
C37H67NO13
 
12560 
Moderate    Inter Info   
[13], [6]
D0687
 
Fluvoxamine
 
C15H21F3N2O2
 
5324346 
Moderate    Inter Info   
[6]
D0740
 
Grepafloxacin
 
C19H22FN3O3
 
72474 
Moderate    Inter Info   
[6]
D0799
 
Indinavir
 
C36H47N5O4
 
5362440 
Moderate    Inter Info   
[13], [6]
D1119
 
Nelfinavir
 
C32H45N3O4S
 
64143 
Moderate    Inter Info   
[13], [6]
D1415
 
Ritonavir
 
C37H48N6O5S2
 
392622 
Moderate    Inter Info   
[13], [6]
   CYP450 enzyme induction Drug Num:  50
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0061
 
Aminoglutethimide
 
C13H16N2O2
 
2145 
Moderate    Inter Info   
[13], [6]
D0178
 
Bexarotene
 
C24H28O2
 
82146 
Moderate    Inter Info   
[13], [6]
D0224
 
Butabarbital
 
C10H16N2O3
 
2479 
Moderate    Inter Info   
[13], [6]
D0225
 
Butalbital
 
C11H16N2O3
 
2481 
Moderate    Inter Info   
[13], [6]
D0071
 
Amobarbital
 
C11H18N2O3
 
2164 
Moderate    Inter Info   
[13], [6]
D0095
 
Apalutamide
 
C21H15F4N5O2S
 
24872560 
Moderate    Inter Info   
[13], [6]
D0194
 
Bosentan
 
C27H29N5O6S
 
104865 
Moderate    Inter Info   
[13], [6]
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Moderate    Inter Info   
[13], [6]
D0300
 
Cenobamate
 
C10H10ClN5O2
 
11962412 
Moderate    Inter Info   
[13], [6]
D0406
 
Dabrafenib
 
C23H20F3N5O2S2
 
44462760 
Moderate    Inter Info   
[13], [6]
D0432
 
Deferasirox
 
C21H15N3O4
 
214348 
Moderate    Inter Info   
[13], [6]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Moderate    Inter Info   
[13], [6]
D0545
 
Echinacea
 
NA
 
NA
Moderate    Inter Info   
[3], [43]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Moderate    Inter Info   
[13], [6]
D0555
 
Elagolix
 
C32H30F5N3O5
 
11250647 
Moderate    Inter Info   
[13], [6]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Moderate    Inter Info   
[13], [6]
D0601
 
Eslicarbazepine
 
C15H14N2O2
 
9881504 
Moderate    Inter Info   
[13], [6]
D0628
 
Etravirine
 
C20H15BrN6O
 
193962 
Moderate    Inter Info   
[13], [6]
D0639
 
Felbamate
 
C11H14N2O4
 
3331 
Moderate    Inter Info   
[13], [6]
D0697
 
Fosphenytoin
 
C16H15N2O6P
 
56339 
Moderate    Inter Info   
[13], [6]
D0872
 
Ivosidenib
 
C28H22ClF3N6O3
 
71657455 
Moderate    Inter Info   
[13], [6]
D0901
 
Lemborexant
 
C22H20F2N4O2
 
56944144 
Moderate    Inter Info   
[13], [61], [6]
D0953
 
Lorlatinib
 
C21H19FN6O2
 
71731823 
Moderate    Inter Info   
[13], [6]
D0958
 
Lumacaftor
 
C24H18F2N2O5
 
16678941 
Moderate    Inter Info   
[13], [61], [6]
D1040
 
Methylphenobarbital
 
C13H14N2O3
 
8271 
Moderate    Inter Info   
[13], [61], [6]
D1078
 
Mitotane
 
C14H10Cl4
 
4211 
Moderate    Inter Info   
[13], [6]
D1099
 
Nafcillin
 
C21H22N2O5S
 
8982 
Moderate    Inter Info   
[13], [6]
D1198
 
Oxcarbazepine
 
C15H12N2O2
 
34312 
Moderate    Inter Info   
[13], [6]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Moderate    Inter Info   
[13], [6]
D1274
 
Phenylbutazone
 
C19H20N2O2
 
4781 
Moderate    Inter Info   
[13], [6]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Moderate    Inter Info   
[13], [6]
D1399
 
Rifabutin
 
C46H62N4O11
 
135398743 
Moderate    Inter Info   
[13], [6]
D1400
 
Rifampicin
 
C43H58N4O12
 
135398735 
Moderate    Inter Info   
[13], [61], [6]
D1401
 
Rifapentine
 
C47H64N4O12
 
135403821 
Moderate    Inter Info   
[13], [6]
D1493
 
Somapacitan
 
C54H95N13O20S2
 
129894493 
Moderate    Inter Info   
[13], [61], [6]
D1495
 
Somatrem
 
C43H72N14O14
 
5487805 
Moderate    Inter Info   
[13], [6]
D1502
 
St. John's Wort
 
NA
 
NA
Moderate    Inter Info   
[13], [6]
D1518
 
Sulfinpyrazone
 
C23H20N2O3S
 
5342 
Moderate    Inter Info   
[13], [6]
D1538
 
Tazemetostat
 
C34H44N4O4
 
66558664 
Moderate    Inter Info   
[13], [6]
D1546
 
Telotristat ethyl
 
C27H26ClF3N6O3
 
25181577 
Moderate    Inter Info   
[4], [83]
D1687
 
Vemurafenib
 
C23H18ClF2N3O3S
 
42611257 
Moderate    Inter Info   
[13], [6]
D0741
 
Griseofulvin
 
C17H17ClO6
 
441140 
Moderate    Inter Info   
[13], [6]
D1128
 
Nevirapine
 
C15H14N4O
 
4463 
Moderate    Inter Info   
[13], [6]
D1248
 
Pentobarbital
 
C11H18N2O3
 
4737 
Moderate    Inter Info   
[13], [6]
D1283
 
Phenytoin
 
C15H12N2O2
 
1775 
Moderate    Inter Info   
[13], [6]
D1453
 
Secobarbital
 
C12H18N2O3
 
5193 
Moderate    Inter Info   
[13], [6]
D1494
 
Somatotropin
 
NA
 
NA
Moderate    Inter Info   
[13], [61], [6]
D1652
 
Troglitazone
 
C24H27NO5S
 
5591 
Moderate    Inter Info   
[13], [6]
D0106
 
Armodafinil
 
C15H15NO2S
 
9690109 
Minor    Inter Info   
[90], [91], [92], [93], [94]
D1081
 
Modafinil
 
C15H15NO2S
 
4236 
Minor    Inter Info   
[90], [91], [92], [93], [94]
   Competitive inhibition of metabolic enzyme Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0696
 
Fosnetupitant
 
C31H35F6N4O5P
 
71544786 
Moderate    Inter Info   
[3], [46], [47]
D1127
 
Netupitant
 
C30H32F6N4O
 
6451149 
Moderate    Inter Info   
[3], [46], [47]
      Pharmacodynamic additive effects
   Additive immunosuppressive effects Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1174
 
Omacetaxine mepesuccinate
 
C29H39NO9
 
285033 
Moderate    Inter Info   
[69]
   Increased risk of hepatotoxicity Drug Num:  22
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[7], [8], [9]
D0944
 
Lomitapide
 
C39H37F6N3O2
 
9853053 
Major    Inter Info   
[10]
D1073
 
Mipomersen
 
C230H324N67O122P19S19
 
118984467 
Major    Inter Info   
[11]
D1258
 
Pexidartinib
 
C20H15ClF3N5
 
25151352 
Major    Inter Info   
[12]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[7], [8], [9]
D0114
 
Asparaginase Escherichia coli
 
NA
 
NA
Moderate    Inter Info   
[14], [15], [16], [3], [4], [17], [18], [19], [20], [21], [22], [23], [24]
D0584
 
Epirubicin
 
C27H29NO11
 
41867 
Moderate    Inter Info   
[3], [4], [27]
D0113
 
Asparaginase Erwinia chrysanthemi
 
NA
 
NA
Moderate    Inter Info   
[14], [15], [16], [3], [4], [17], [18], [19], [20], [21], [22], [23], [24]
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Moderate    Inter Info   
[32]
D0199
 
Brentuximab vedotin
 
NA
 
NA
Moderate    Inter Info   
[33]
D0232
 
Calaspargase pegol
 
NA
 
NA
Moderate    Inter Info   
[14], [15], [16], [3], [4], [17], [18], [19], [20], [21], [22], [23], [24]
D0248
 
Cannabidiol
 
C21H30O2
 
644019 
Moderate    Inter Info   
[4], [36]
D0357
 
Clofarabine
 
C10H11ClFN5O3
 
119182 
Moderate    Inter Info   
[38]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Moderate    Inter Info   
[51]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[4], [63]
D1106
 
Naltrexone
 
C20H23NO4
 
5360515 
Moderate    Inter Info   
[67]
D1239
 
Peginterferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72], [73]
D1389
 
Remdesivir
 
C27H35N6O8P
 
121304016 
Moderate    Inter Info   
[3], [4], [76], [77], [78]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Moderate    Inter Info   
[4], [86]
D0826
 
Interferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72], [73]
D0827
 
Interferon beta-1b
 
NA
 
NA
Moderate    Inter Info   
[70], [71], [72], [73]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Moderate    Inter Info   
[87], [88]
   Increased risk of photosensitivity reactions Drug Num:  6
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0062
 
Aminolevulinic acid
 
C5H9NO3
 
137 
Major    Inter Info   
[1], [2]
D0063
 
Aminolevulinic acid (topical)
 
C5H9NO3
 
137 
Moderate    Inter Info   
[3], [4], [31]
D1028
 
Methoxsalen
 
C12H8O4
 
4114 
Moderate    Inter Info   
[3], [64], [1], [65], [66]
D1033
 
Methyl aminolevulinate (topical)
 
C6H11NO3
 
157922 
Moderate    Inter Info   
[3], [4], [31]
D1314
 
Porfimer sodium
 
C68H74N8O11
 
135577896 
Moderate    Inter Info   
[74], [4], [75]
D1691
 
Verteporfin
 
C82H84N8O16
 
11980904 
Moderate    Inter Info   
[4], [64], [1], [89]
   Increased risk of other adverse reactions (Unspecific) Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1426
 
Romosozumab
 
NA
 
NA
Moderate    Inter Info   
[81]
References
1 Product Information. Nulibry (fosdenopterin). Origin Biosciences Inc, Boston, MA.
2 Product Information. Gleolan (aminolevulinic acid). NX Development Corp, Lexington, KY.
3 Cerner Multum, Inc. "Australian Product Information.".
4 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
5 Duong S, Leung M "Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents." J Oncol Pharm Pract 17 (2011): 448-52. [PMID: 20716581]
6 Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
7 Canadian Pharmacists Association.
8 EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
9 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
10 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
11 Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
12 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
13 Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
14 Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
15 Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
16 Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
17 Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
18 Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
19 Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
20 Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
21 Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
22 Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
23 Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
24 Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
25 Guo LQ, Yamazoe Y "Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines." Acta Pharmacol Sin 25 (2004): 129-36. [PMID: 14769198]
26 Thomas KS, Billingsley A, Amarshi N, Nair BA "Elevated International Normalized Ratio associated with concomitant warfarin and erlotinib." Am J Health Syst Pharm 67 (2010): 1426-9. [PMID: 20720241]
27 Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
28 Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
29 Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
30 Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
31 Product Information. Metvixia (methyl aminolevulinate topical). Galderma Laboratories Inc, Cranbury, NJ.
32 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
33 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
34 Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
35 Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
36 Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
37 Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
38 Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
39 Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
40 Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
41 Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
42 Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
43 Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
44 Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
45 Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
46 Product Information. Akynzeo (netupitant-palonosetron). Eisai Inc, Woodcliff Lake, NJ.
47 Product Information. Akynzeo for Injection (fosnetupitant-palonosetron). Helsinn Therapeutics Inc, Woodbridge Township, NJ.
48 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
49 Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
50 Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
51 Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
52 Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
53 Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
54 Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
55 Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
56 Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
57 Product Information. Harvoni (ledipasvir-sofosbuvir). Gilead Sciences, Foster City, CA.
58 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
59 Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
60 Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
61 Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
62 Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
63 Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
64 Multum Information Services, Inc. Expert Review Panel.
65 Product Information. Oxsoralen (methoxsalen). ICN Pharmaceuticals Inc, Costa Mesa, CA.
66 Product Information. Uvadex (methoxsalen). Therakos Inc, Exton, PA.
67 Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
68 Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
69 Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
70 Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
71 Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
72 Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
73 Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
74 Blakely KM, Drucker AM, Rosen CF "Drug-induced photosensitivity-an update: Culprit drugs, prevention and management." Drug Saf 42 (2019): 827-47. [PMID: 30888626]
75 Product Information. Photofrin (porfimer). Sanofi Winthrop Pharmaceuticals, New York, NY.
76 European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
77 Gilead Sciences, Inc "About Remdesivir.".
78 US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
79 Product Information. Ziagen (abacavir). Glaxo Wellcome, Research Triangle Pk, NC.
80 Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
81 Product Information. Evenity (romosozumab). Amgen USA, Thousand Oaks, CA.
82 Product Information. Lokelma (sodium zirconium cyclosilicate). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
83 Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
84 Product Information. Jynarque (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
85 Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
86 Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
87 Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
88 Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
89 Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
90 Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
91 Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
92 Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
93 Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
94 Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]